SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-251349
Filing Date
2015-07-13
Accepted
2015-07-13 17:14:36
Documents
6
Period of Report
2015-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d54024d8k.htm 8-K 17432
2 EX-1.1 d54024dex11.htm EX-1.1 162539
3 EX-5.1 d54024dex51.htm EX-5.1 5328
4 EX-99.1 d54024dex991.htm EX-99.1 5291
5 EX-99.2 d54024dex992.htm EX-99.2 5434
6 GRAPHIC g54024g60i68.jpg GRAPHIC 2208
  Complete submission text file 0001193125-15-251349.txt   200366
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 15986001
SIC: 2834 Pharmaceutical Preparations